Royal Sense Limited (BSE SME)
Mar 12, 2024 - Mar 14, 2024
| Price | ₹68 - ₹68 |
| Premium | ₹37 |
|---|---|
| Lot size | 2000 |
| Allotment | Mar 15, 2024 |
| Listing | Mar 19, 2024 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 2000 | 136000 | 323 |
| HNI | 2 | 4000 | 272000 | 322 |
Last updated on 14 Mar 2024 | 05:53:49 PM
| Category | Offered | Applied | Times |
|---|---|---|---|
| HNIs | 644000 | 6434000 | 9.99 |
| Retail | 646000 | 4720000 | 7.31 |
| Total | 1290000 | 11154000 | 8.65 |
| Total Application : 3,198 | |||
| HNI Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹0.91 | @8% ₹1.04 | @9% ₹1.17 | @10% ₹1.3 | @11% ₹1.43 | @12% ₹1.56 |
IPO Reservation
| Investor Category | Shares Offered | No. of Shares |
|---|---|---|
| Retail | 44.5% | 646000 |
| NII (HNI) | 44.4% | 644000 |
| Market Maker | 11.03% | 160000 |
| Total No. of Shares | 100.0% | 1450000 |
Royal Sense Limited, established in 2023, specializes in providing a wide array of medical equipment, surgical instruments, consumables, laboratory essentials, and diagnostic kits. Initially operating under the proprietorship of Mr. Rishabh Arora as "M/s Royal Traders, PHT and Anaya," the company transitioned into its current form upon acquisition on April 28, 2023. With a focus on serving the Ministry of Health Departments across states such as Uttar Pradesh, Himachal Pradesh, Rajasthan, and Jammu & Kashmir, as well as government institutions and private hospitals nationwide, Royal Sense Limited plays a crucial role in supplying essential healthcare products. As of June 30, 2023, the company boasted a dedicated workforce of 8 individuals, contributing their expertise across various departments to ensure the seamless delivery of quality medical solutions to its clientele.
Royal Sense IPO Details
| Issue Size | 1,450,000 shares (aggregating up to ₹9.86 Cr) |
| Fresh Issue | 1,450,000 shares (aggregating up to ₹9.86 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Share holding pre issue | 3,450,146 |
| Share holding post issue | 4,900,146 |
| Market Maker portion | 160,000 shares Rikhav securities |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 17.00% |
| ROCE | 23.00% |
| RoNW | 17.00% |
| P/BV | 5.65 |
| EPS (basic & diluted) | 2.04 |
| P/E | 33.33 |
Company Financials
Royal Sense Limited Financial Information (Restated)
| Period | Sep 2023 |
|---|---|
| Assets | 569.87 |
| Revenue | 804.07 |
| Profit | 70.28 |
| Net Worth | 415.29 |
| Reserves | 70.28 |
| Borrowings | 27.58 |
| Amount in ₹ Lakhs | |
Strength Factors
Experience of the Promoter and Core Management Team: Royal Sense Limited benefits from the leadership of a seasoned team with deep-rooted experience in the healthcare sector. Their collective expertise guides the company's strategic vision and operational efficiency, contributing to its overall success.
Diversified Range of Products: The Company offers a wide selection of healthcare products, spanning medical equipment, surgical instruments, consumables, laboratory essentials, and diagnostic kits. This diverse portfolio caters to various healthcare requirements, providing customers with comprehensive solutions.
Existing Well-Established Reputation and Customer Relationships: Royal Sense Limited has earned a solid reputation for reliability and quality, fostering enduring relationships with government institutions and private hospitals nationwide. This established trust underscores the company's commitment to customer satisfaction and service excellence.
Cost Competitiveness and Time-Bound Delivery: The Company maintains a competitive edge through efficient cost management practices while ensuring timely delivery of orders. Their emphasis on streamlined processes and supply chain efficiency enables them to offer competitive pricing without compromising on delivery timelines.
Stable Financial Performance with Improved Margins: Royal Sense Limited demonstrates consistent financial performance, marked by steady growth and enhanced profitability. Their prudent financial management strategies have resulted in improved margins, reinforcing their financial stability and long-term viability.
Risk Factors
Dependence on External Suppliers: The Company relies heavily on suppliers for medical devices and equipment, which are essential for its trading operations. Any disruption in the supply chain could lead to shortages, affecting business operations, profitability, and customer satisfaction.
Vulnerability to Healthcare Spending Trends: The Company’s revenue is closely tied to customer spending in the healthcare industry. A decline in healthcare infrastructure spending in India could adversely impact the company's financial performance and overall business viability.
Uncertain Customer Orders: There is a risk of customer orders being delayed, modified, canceled, or not fully paid for. Such occurrences could disrupt cash flow, lead to inventory management challenges, and negatively impact the company's financial stability.
Limited Operating History: As a newly incorporated company with limited operating history, investors may find it challenging to assess the company's historical performance and future prospects accurately. This lack of historical data may deter potential investors or stakeholders.
Regulatory Compliance Challenges: The Company is required to obtain and maintain various statutory and regulatory permits and approvals to operate its business legally. Failure to obtain or renew these permits in a timely manner could lead to regulatory penalties, business disruptions, and financial losses.
Royal Sense IPO Lead Manager(s)
- Expert Global Consultants Private Limited
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html